Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The interleukin-6 promoter polymorphism in Gaucher disease: a new modifier gene?

QJM : monthly journal of the Association of Physicians - 1 Aug 2003

Altarescu G, Phillips M, Foldes A J, Elstein D, Zimran A, Mates M

Abstract excerpt

BACKGROUND: Individuals with Gaucher disease vary significantly with regard to degree of bone disease, but there are no predictive markers for severity of skeletal involvement. AIM: To determine the frequency of polymorphisms of interleukin-6 (IL-6) among patients with Gaucher disease, and the re...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Density
Share to Case-Control Studies
Share to Gaucher Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukin-6

Share to Polymorphism, Genetic

Share to Promoter Regions, Genetic

Share to Severity of Illness Index

Source

Identifiers

PMID: 12897342
DOI: 10.1093/qjmed/hcg097

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12897342-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The interleukin-6 promoter polymorphism in Gaucher disease: a new modifier gene?PMID 12897342Read ↗

Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease.Semantic proximity Read ↗

The influence of genetic variability and proinflammatory status on the development of bone disease in patients with Gaucher disease.Semantic proximity Read ↗

Molecular aspects of osteopathy in type 1 Gaucher disease: correlation between genetics and bone density.Semantic proximity Read ↗

Correlation between interleukin-6 promoter and C-reactive protein (CRP) polymorphisms and CRP levels with the Mainz Severity Score Index for Fabry disease.Semantic proximity Read ↗

Effect of vitamin D receptor (VDR) genotypes on the risk for osteoporosis in type 1 Gaucher disease.Semantic proximity Read ↗

Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications.Semantic proximity Read ↗

Vitamin D Receptor (VDR) polymorphic variants in patients with cancer and Gaucher disease.Semantic proximity Read ↗

Correlation of MRI-Based bone marrow burden score with genotype and spleen status in Gaucher's disease.Semantic proximity Read ↗

Polymorphisms in glucosylceramide (glucocerebroside) synthase and the Gaucher disease phenotype.Semantic proximity Read ↗

Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis.Semantic proximity Read ↗

Bone density in Type 1 Gaucher disease.Semantic proximity Read ↗

Cytokines in Gaucher's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.